Financial Statements

Bayer Group Consolidated Statements of Financial Position

	[Table 21]
	Sep. 30, 2010	Sep. 30, 2011	Dec. 31, 2010
	€ million	€ million	€ million
Noncurrent assets
Goodwill	8,917	9,047	9,002
Other intangible assets	12,081	10,430	11,161
Property, plant and equipment	9,602	9,480	9,835
Investments accounted for using the equity method	361	319	354
Other financial assets	1,267	1,113	1,164
Other receivables	478	408	498
Deferred taxes	1,838	1,246	1,174
	34,544	32,043	33,188
Current assets
Inventories	6,341	6,539	6,104
Trade accounts receivable	6,796	7,025	6,668
Other financial assets	463	3,063	1,008
Other receivables	1,535	1,619	1,336
Claims for income tax refunds	258	436	362
Cash and cash equivalents	2,124	1,181	2,840
Assets held for sale	-	15	-
	17,517	19,878	18,318

Total assets	52,061	51,921	51,506

Equity
Capital stock of Bayer AG	2,117	2,117	2,117
Capital reserves of Bayer AG	6,167	6,167	6,167
Other reserves	9,939	10,665	10,549
Equity attributable to Bayer AG stockholders	18,223	18,949	18,833
Equity attributable to non-controlling interest	58	59	63
	18,281	19,008	18,896

Noncurrent liabilities
Provisions for pensions and other post-employment benefits	8,297	7,524	7,305
Other provisions	1,498	1,754	1,478
Financial liabilities	10,367	7,521	9,944
Other liabilities	475	500	471
Deferred taxes	2,969	2,401	2,577
	23,606	19,700	21,775
Current liabilities
Other provisions	4,108	4,593	3,870
Financial liabilities	1,618	3,721	1,889
Trade accounts payable	2,870	3,397	3,497
Income tax liabilities	47	46	62
Other liabilities	1,531	1,456	1,517
	10,174	13,213	10,835

Total equity and liabilities	52,061	51,921	51,506
2010 figures restated

Last updated: October 27, 2011

http://www.stockholders-newsletter-q3-2011.bayer.com/en/financial-position.aspx

Copyright © Bayer AG